Improving Titer, Quality and Efficiency of AAV Manufacturing and Production by Optimizing Osmolality

Article

Sponsored Content

Modulating osmolality in the early stages of AAV1 upstream manufacturing, can result in improved outcomes such as overall yield, quality, reduced manufacturing costs and improved efficiencies.

Related Content
© 2024 MJH Life Sciences

All rights reserved.